NeoGenomics Inc.

NASDAQ: NEO
Share price (6/17/25): $6.99
Market cap (6/17/25): $900 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 62 pages Dated May 4, 2021 Between the Initial Sellers and Neogenomics Laboratories, Inc. as Buyer and Inivata Limited as the Company Share Purchase Agreement Relating to the Sale and Purchase of the Entire Issued Share Capital of Inivata Limited

from 8-K 41 pages Asset Purchase Agreement Between Human Longevity, Inc. and Neogenomics Laboratories, Inc. Dated as of January 10, 2020

from 8-K 119 pages Plan of reorganization, merger, acquisition or similar

from 8-K 6 pages Amendment No. 1 to Stock Purchase Agreement

from 8-K 61 pages Membership Interest Purchase Agreement by and Among Neogenomics Laboratories, Inc., as Buyer, Path Labs, LLC, as the Company and Path Labs Holdings, LLC, as Seller July 8, 2014

from 10QSB ~10 pages Agreement and Plan of Exchange

from 8-K 1 page Amendement Between Tampa Bay Financial and "Tbf"

from 8-K ~5 pages Letter of Intent

from 8-K ~20 pages Asset Purchase Agreement - Watts